ERINI, GIULIA
ERINI, GIULIA
AFORM - AREA FORMAZIONE E DOTTORATO
A systematic review of cancer risks associated with MITF variants
2026 Monti, Luigi; Godino, Lea; Dessinioti, Clio; Stratigos, Alex; Papadodima, Olga; Pintzas, Alexander; Nicoară, Delia; Albert, Yvette; Boccia, Stefania; Barbato, Sara; Erini, Giulia; Miccoli, Sara; Innella, Giovanni; Turchetti, Daniela
Cascade testing as the missing link in cancer prevention among Lynch syndrome families
2026 Godino, Lea; Erini, Giulia; Innella, Giovanni; Miccoli, Sara; Ferrari, Simona; Magini, Pamela; Caramanna, Luca; Preite, Martina; Simoni, Veronica; Turchetti, Daniela
Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients
2025 Innella, G.; Erini, G.; De Leo, A.; Godino, L.; Caramanna, L.; Ferrari, S.; Miccoli, S.; Perrone, A. M.; Zamagni, C.; De Iaco, P.; Turchetti, D.; Rucci, P.
Machine learning prediction of germline BRCA1/2 pathogenic variants in patients with ovarian cancer
2025 Innella, Giovanni; Erini, Giulia; De Leo, Antonio; Godino, Lea; Caramanna, Luca; Ferrari, Simona; Miccoli, Sara; Perrone, Anna Myriam; Zamagni, Claudio; De Iaco, Pierandrea; Turchetti, Daniela; Rucci, Paola
Response to: Re: ‘Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients’
2025 Innella, G.; Erini, G.; De Leo, A.; Godino, L.; Caramanna, L.; Ferrari, S.; Miccoli, S.; Perrone, A. M.; Zamagni, C.; De Iaco, P.; Turchetti, D.; Rucci, P.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| A systematic review of cancer risks associated with MITF variants | Monti, Luigi; Godino, Lea; Dessinioti, Clio; Stratigos, Alex; Papadodima, Olga; Pintzas, Alexande...r; Nicoară, Delia; Albert, Yvette; Boccia, Stefania; Barbato, Sara; Erini, Giulia; Miccoli, Sara; Innella, Giovanni; Turchetti, Daniela | 2026-01-01 | FAMILIAL CANCER | - | 1.01 Articolo in rivista | - |
| Cascade testing as the missing link in cancer prevention among Lynch syndrome families | Godino, Lea; Erini, Giulia; Innella, Giovanni; Miccoli, Sara; Ferrari, Simona; Magini, Pamela; Ca...ramanna, Luca; Preite, Martina; Simoni, Veronica; Turchetti, Daniela | 2026-01-01 | FAMILIAL CANCER | - | 1.01 Articolo in rivista | - |
| Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients | Innella, G.; Erini, G.; De Leo, A.; Godino, L.; Caramanna, L.; Ferrari, S.; Miccoli, S.; Perrone,... A. M.; Zamagni, C.; De Iaco, P.; Turchetti, D.; Rucci, P. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | 1-s2.0-S205970292501169X-main.pdf; 1-s2.0-S205970292501169X-mmc1.docx |
| Machine learning prediction of germline BRCA1/2 pathogenic variants in patients with ovarian cancer | Innella, Giovanni; Erini, Giulia; De Leo, Antonio; Godino, Lea; Caramanna, Luca; Ferrari, Simona;... Miccoli, Sara; Perrone, Anna Myriam; Zamagni, Claudio; De Iaco, Pierandrea; Turchetti, Daniela; Rucci, Paola | 2025-01-01 | BMJ HEALTH & CARE INFORMATICS | - | 1.01 Articolo in rivista | e101751.full.pdf |
| Response to: Re: ‘Development of a risk score based on clinical–pathological features to predict the presence of germline BRCA1/2 pathogenic variants in ovarian cancer patients’ | Innella, G.; Erini, G.; De Leo, A.; Godino, L.; Caramanna, L.; Ferrari, S.; Miccoli, S.; Perrone,... A. M.; Zamagni, C.; De Iaco, P.; Turchetti, D.; Rucci, P. | 2025-01-01 | ESMO OPEN | - | 1.01 Articolo in rivista | 1-s2.0-S205970292501631X-main.pdf |